Physician profile
Sarah Johnson
NPI 1316477102
$2,753.67
in general payments reported to CMS, 2019-2025
26 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $435 · 2022: $1,012 · 2023: $450 · 2024: $486 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,306.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $612.69 | 2022-2023 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $611.15 | 2023-2025 | General - Therapies, Lux-Dx Insertable Cardiac Monitor, General - Pain Management |
| Medtronic, INC. | $485.49 | 2021-2023 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $305.89 | 2021-2025 | Xtampza, Belbuca |
| Pfizer INC. | $94.25 | 2021 | |
| Horizon Therapeutics Plc | $61.07 | 2021-2022 | |
| Abbvie INC. | $51.90 | 2023-2024 | |
| Abbott Laboratories | $48.95 | 2021-2023 | Eterna |
| Relievant Medsystems, INC. | $44.61 | 2022 | |
| Curonix LLC | $38.20 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biodelivery Sciences International, INC. | $37.55 | 2021 | |
| Nalu Medical, INC. | $37.07 | 2021-2024 | Nalu Neurostimulation System |
| Stimwave Technologies Incorporated | $37.07 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $36.90 | 2022 | |
| Arbor Pharmaceuticals, INC. | $36.38 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $33.01 | 2024-2025 | Evoke |
| Si-Bone, INC. | $26.96 | 2025 | |
| Grt US Holding, INC. | $21.53 | 2022 | |
| Biotronik Nro, INC. | $18.39 | 2025 | Prospera |
| Protega Pharmaceutials INC | $17.86 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.38 | 2022 | |
| Averitas Pharma INC. | $16.79 | 2024 | Qutenza |
| Ibsa Pharma INC. | $16.16 | 2022 | |
| Painteq LLC | $15.91 | 2023 | Painteq |
| Convatec INC. | $15.60 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.